The DOI matches its Crossref record; 197 of the 197 references it cites were found in a registry or an index.
Opioid antagonists for alcohol dependence
Abstract
BACKGROUND: Alcohol dependence belongs to the globally leading health risk factors. Therapeutic success of psychosocial programs for relapse prevention is moderate and could be increased by an adjuvant treatment with the opioid antagonists naltrexone and nalmefene. OBJECTIVES: To determine the effectiveness and tolerability of opioid antagonists in the treatment of alcohol dependence. SEARCH STRATEGY: We searched the Cochrane Drugs and Alcohol Group (CDAG) Specialized Register, PubMed, EMBASE and CINAHL in January 2010 and inquired manufacturers and researchers for unpublished trials. SELECTION CRITERIA: All double-blind randomised controlled trials (RCTs) which compare the effects of naltrexone or nalmefene with placebo or active control on drinking-related outcomes. DATA COLLECTION AND ANALYSIS: Two authors independently extracted outcome data. Trial quality was assessed by one author and cross-checked by a second author. MAIN RESULTS: Based on a total of 50 RCTs with 7793 patients, naltrexone reduced the risk of heavy drinking to 83% of the risk in the placebo group RR 0.83 (95% CI 0.76 to 0.90) and decreased drinking days by about 4%, MD -3.89 (95% CI -5.75 to -2.04). Significant effects were also demonstrated for the secondary outcomes of the review including heavy drinking days, MD - 3.25 (95% CI -5.51 to -0.99), consumed amount of alcohol, MD - 10.83 (95% CI -19.69 to -1.97) and gamma-glutamyltransferase, MD - 10.37 (95% CI -18.99 to -1.75), while effects on return to any drinking, RR 0.96 (95 CI 0.92 to 1.00) missed statistical significance. Side effects of naltrexone were mainly gastrointestinal problems (e.g. nausea: RD 0.10; 95% CI 0.07 to 0.13) and sedative effects (e.g. daytime sleepiness: RD 0.09; 95% CI 0.05 to 0.14). Based on a limited study sample, effects of injectable naltrexone and nalmefene missed statistical significance. Effects of industry-sponsored studies, RR 0.90 (95% CI 0.78 to 1.05) did not significantly differ from those of non-profit funded trials, RR 0.84 (95% CI 0.77 to 0.91) and the linear regression test did not indicate publication bias (P = 0.765). AUTHORS' CONCLUSIONS: Naltrexone appears to be an effective and safe strategy in alcoholism treatment. Even though the sizes of treatment effects might appear moderate in their magnitudes, these should be valued against the background of the relapsing nature of alcoholism and the limited therapeutic options currently available for its treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Kessler, R. C. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950010008002 · Cited by 12,370
Cohen, J. (1992) · Psychological Bulletin · doi:10.1037//0033-2909.112.1.155 · Cited by 8,771
Confirmation Bias: A Ubiquitous Phenomenon in Many Guises
Nickerson, R. S. (1998) · Review of General Psychology · doi:10.1037/1089-2680.2.2.175 · Cited by 7,267
Schulz (1995) · doi:10.1001/jama.1995.03520290060030 · Cited by 5,634
The Hopkins Symptom Checklist (HSCL): A self-report symptom inventory
Derogatis, L. R., Lipman, R. S., Rickels, K., Uhlenhuth, E. H., & Covi, L. (1974) · Behavioral Science · doi:10.1002/bs.3830190102 · Cited by 4,604
Rehm, J., Mathers, C., Popova, S., Thavorncharoensap, M., Teerawattananon, Y., & Patra, J. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60746-7 · Cited by 3,870
McLELLAN, A. T., LUBORSKY, L., WOODY, G. E., & O??BRIEN, C. P. (1980) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-198001000-00006 · Cited by 3,188
Wood, L., Egger, M., Gluud, L. L., Schulz, K. F., Jüni, P., Altman, D. G., Gluud, C., Martin, R. M., Wood, A. J. G., & Sterne, J. A. C. (2008) · BMJ · doi:10.1136/bmj.39465.451748.ad · Cited by 2,538
Regier, D. A. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820140007001 · Cited by 1,999
SULLIVAN, J. T., SYKORA, K., SCHNEIDERMAN, J., NARANJO, C. A., & SELLERS, E. M. (1989) · British Journal of Addiction · doi:10.1111/j.1360-0443.1989.tb00737.x · Cited by 1,988
Anton, R. F., O’Malley, S. S., Ciraulo, D. A., Cisler, R. A., Couper, D., Donovan, D. M., Gastfriend, D. R., Hosking, J. D., Johnson, B. A., LoCastro, J. S., et al. (2006) · JAMA · doi:10.1001/jama.295.17.2003 · Cited by 1,930
Chan, A.-W., Hróbjartsson, A., Haahr, M. T., Gøtzsche, P. C., & Altman, D. G. (2004) · JAMA · doi:10.1001/jama.291.20.2457 · Cited by 1,845
Naltrexone in the Treatment of Alcohol Dependence
Volpicelli, J. R. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820110040006 · Cited by 1,828
Analysing Data and Undertaking Meta‐Analyses
Deeks, J. J., Higgins, J. P., & Altman, D. G. (2008) · Cochrane Handbook for Systematic Reviews of Interventions · doi:10.1002/9780470712184.ch9 · Cited by 1,800
Lingjærde, O., Ahlfors, U. G., Bech, P., Dencker, S. J., & Elgen, K. (1987) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1987.tb10566.x · Cited by 1,705
Naltrexone and Coping Skills Therapy for Alcohol Dependence: A Controlled Study
O'Malley, S. S. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820110045007 · Cited by 1,487
Undue reliance on I 2 in assessing heterogeneity may mislead
Rücker, G., Schwarzer, G., Carpenter, J. R., & Schumacher, M. (2008) · BMC Medical Research Methodology · doi:10.1186/1471-2288-8-79 · Cited by 1,287
Statistics Notes: Detecting skewness from summary information: Table 1
Altman, D. G., & Bland, J. M. (1996) · BMJ · doi:10.1136/bmj.313.7066.1200 · Cited by 1,278
Alcohol dependence syndrome: Measurement and validation.
Skinner, H. A., & Allen, B. A. (1982) · Journal of Abnormal Psychology · doi:10.1037//0021-843x.91.3.199 · Cited by 1,061
Moher, D., Jones, A., Lepage, L., & for the CONSORT Group (2001) · JAMA · doi:10.1001/jama.285.15.1992 · Cited by 1,027
Reward-motivated learning: mesolimbic activation precedes memory formation
Adcock, R. A., Thangavel, A., Whitfield-Gabrieli, S., Knutson, B., & Gabrieli, J. D. E. (2006) · Neuron · doi:10.1016/j.neuron.2006.03.036 · Cited by 977
Comparison of Evidence of Treatment Effects in Randomized and Nonrandomized Studies
Ioannidis, J. P. A. (2001) · JAMA · doi:10.1001/jama.286.7.821 · Cited by 919
Endogenous opioid systems and alcohol addiction
Herz, A. (1997) · Psychopharmacology · doi:10.1007/s002130050169 · Cited by 759
Intention-to-Treat Analysis: Implications for Quantitative and Qualitative Research
NEWELL, D. J. (1992) · International Journal of Epidemiology · doi:10.1093/ije/21.5.837 · Cited by 715
Statistical Problems in the Reporting of Clinical Trials
Pocock, S. J., Hughes, M. D., & Lee, R. J. (1987) · New England Journal of Medicine · doi:10.1056/nejm198708133170706 · Cited by 662
Garbutt, J. C., Kranzler, H. R., O’Malley, S. S., Gastfriend, D. R., Pettinati, H. M., Silverman, B. L., Loewy, J. W., Ehrich, E. W., & Vivitrex Study Group, F. T. (2005) · JAMA · doi:10.1001/jama.293.13.1617 · Cited by 635
Naltrexone in the Treatment of Alcohol Dependence
Krystal, J. H., Cramer, J. A., Krol, W. F., Kirk, G. F., & Rosenheck, R. A. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011127 · Cited by 618
Rates and predictors of relapse after natural and treated remission from alcohol use disorders
Moos, R. H., & Moos, B. S. (2006) · Addiction · doi:10.1111/j.1360-0443.2006.01310.x · Cited by 601
A comparison of statistical methods for meta‐analysis
Brockwell, S. E., & Gordon, I. R. (2001) · Statistics in Medicine · doi:10.1002/sim.650 · Cited by 573
Oslin, D. W., Berrettini, W., Kranzler, H. R., Pettinati, H., Gelernter, J., Volpicelli, J. R., & O'Brien, C. P. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300219 · Cited by 571
Lefebvre, C., Manheimer, E., & Glanville, J. (2008) · Cochrane Handbook for Systematic Reviews of Interventions · doi:10.1002/9780470712184.ch6 · Cited by 559
Subverting Randomization in Controlled Trials
Schulz, K. F. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530180050029 · Cited by 516
Carmen, B., Angeles, M., Ana, M., & María, A. J. (2004) · Addiction · doi:10.1111/j.1360-0443.2004.00763.x · Cited by 504
O'Malley, S., Krishnan-Sarin, S., Farren, C., Sinha, R., & Kreek, M. (2002) · Psychopharmacology · doi:10.1007/s002130100919 · Cited by 492
Impact of allocation concealment on conclusions drawn from meta-analyses of randomized trials
Pildal, J., Hrobjartsson, A., Jorgensen, K., Hilden, J., Altman, D., & Gotzsche, P. (2007) · International Journal of Epidemiology · doi:10.1093/ije/dym087 · Cited by 472
Anton, R. F., Oroszi, G., O’Malley, S., Couper, D., Swift, R., Pettinati, H., & Goldman, D. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.2.135 · Cited by 451
Pharmacological Treatment of Alcohol Dependence: A Review of the Evidence
Garbutt, J. C., West, S. L., Carey, T. S., Lohr, K. N., & Crews, F. T. (1999) · JAMA · doi:10.1001/jama.281.14.1318 · Cited by 444
Anton, R. F., Moak, D. H., Waid, L. R., Latham, P. K., Malcolm, R. J., & Dias, J. K. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.11.1758 · Cited by 425
The Development of a Questionnaire to Measure Severity of Alcohol Dependence *
Stockwell, T., Hodgson, R., Edwards, G., Taylor, C., & Rankin, H. (1979) · British Journal of Addiction to Alcohol & Other Drugs · doi:10.1111/j.1360-0443.1979.tb02415.x · Cited by 419
Naltrexone and Alcohol Dependence: Role of Subject Compliance
Volpicelli, J. R. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830200071010 · Cited by 411
Psychotherapy for Opiate Addicts: Does It Help?
Woody, G. E. (1983) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.04390010049006 · Cited by 408
Kiefer, F., Jahn, H., Tarnaske, T., Helwig, H., Briken, P., Holzbach, R., Kämpf, P., Stracke, R., Baehr, M., Naber, D., et al. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.1.92 · Cited by 400
Quality of Reporting of Randomized Trials as a Measure of Methodologic Quality
Huwiler-Müntener, K. (2002) · JAMA · doi:10.1001/jama.287.21.2801 · Cited by 397
Alteration of ethanol self-administration by naltrexone
Altshuler, H. L., Phillips, P. E., & Feinhandler, D. A. (1980) · Life Sciences · doi:10.1016/0024-3205(80)90257-x · Cited by 397
Efficacy of Naltrexone and Acamprosate for Alcoholism Treatment: A Meta‐Analysis
Kranzler, H. R., & Van Kirk, J. (2001) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2001.tb02356.x · Cited by 390
Treatment of cocaine and alcohol dependence with psychotherapy and disulfiram
Carroll, K. M., Nich, C., Ball, S. A., Mccance, E., & Rounsavile, B. J. (1998) · Addiction · doi:10.1046/j.1360-0443.1998.9357137.x · Cited by 375
The pharmacological treatment of alcohol dependence.
Swift, R. M. (1997) · PubMed · Cited by 372
Antidepressants versus placebo for depression in primary care
Arroll, B., Elley, C. R., Fishman, T., Goodyear-Smith, F. A., Kenealy, T., Blashki, G., Kerse, N., & MacGillivray, S. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007954 · Cited by 352
Active placebos versus antidepressants for depression
Moncrieff, J., Wessely, S., & Hardy, R. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003012.pub2 · Cited by 342
Rating the quality of evidence for clinical practice guidelines
Hadorn, D. C., Baker, D., Hodges, J. S., & Hicks, N. (1996) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(96)00019-4 · Cited by 332
Chick, J. (2000) · Alcohol and Alcoholism · doi:10.1093/alcalc/35.6.587 · Cited by 310
Effect of naltrexone on alcohol “high” in alcoholics
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.4.613 · Cited by 308
Rösner, S., Leucht, S., Lehert, P., & Soyka, M. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107078308 · Cited by 300
Development of a questionnaire to measure alcohol dependence
Raistrick, D., Dunbar, G., & Davidson, R. (1983) · British Journal of Addiction · doi:10.1111/j.1360-0443.1983.tb02484.x · Cited by 292
Anti-craving compounds for ethanol: new pharmacological tools to study addictive processes
Spanagel, R., & Zieglgänsberger, W. (1997) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(97)89800-8 · Cited by 291
Six-Month Follow-up of Naltrexone and Psychotherapy for Alcohol Dependence
O'Malley, S. S. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830030039007 · Cited by 282
Endogenous Opioids and Addiction to Alcohol and other Drugs of Abuse
Gianoulakis, C. (2004) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026043451573 · Cited by 281
A double-blind, placebo-controlled study of oral nalmefene for alcohol dependence
Mason, B. J., Salvato, F. R., Williams, L. D., Ritvo, E. C., & Cutler, R. B. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.8.719 · Cited by 271
Should Unpublished Data Be Included in Meta-analyses?: Current Convictions and Controversies
Cook, D. J. (1993) · JAMA · doi:10.1001/jama.1993.03500210049030 · Cited by 259
Myrick, H., Anton, R. F., Li, X., Henderson, S., Randall, P. K., & Voronin, K. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.4.466 · Cited by 258
Ray, L. A., & Hutchison, K. E. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.9.1069 · Cited by 258
Mason, B. J., Ritvo, E. C., Morgan, R. O., Salvato, F. R., Goldberg, G., Welch, B., & Mantero‐Atienza, E. (1994) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.1994.tb00098.x · Cited by 248
Monti, P. M., Rohsenow, D. J., Swift, R. M., Gulliver, S. B., Colby, S. M., Mueller, T. I., Brown, R. A., Gordon, A., Abrams, D. B., Niaura, R. S., et al. (2001) · Alcoholism: Clinical and Experimental Research · doi:10.1097/00000374-200111000-00011 · Cited by 233
Emmerson, P. J., Liu, M. R., Woods, J. H., & Medzihradsky, F. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24051-4 · Cited by 232
Streeton, C. (2001) · Alcohol and Alcoholism · doi:10.1093/alcalc/36.6.544 · Cited by 228
King, A. C., Volpicelli, J. R., Frazer, A., & O'Brien, C. P. (1997) · Psychopharmacology · doi:10.1007/s002130050156 · Cited by 227
Heinälä, P., Alho, H., Kiianmaa, K., Lönnqvist, J., Kuoppasalmi, K., & Sinclair, J. D. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200106000-00006 · Cited by 226
Sobell, L. C., Sobell, M. B., Riley, D. M., Schuller, R., Pavan, D. S., Cancilla, A., Klajner, F., & Leo, G. I. (1988) · Journal of Studies on Alcohol · doi:10.15288/jsa.1988.49.225 · Cited by 218
Naltrexone for the treatment of alcoholism: a meta-analysis of randomized controlled trials
Srisurapanont, M., & Jarusuraisin, N. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145704004997 · Cited by 216
Self-citationCroop, R. S. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830240090013 · Cited by 211
Naltrexone vs. Nefazodone for Treatment of Alcohol Dependence A Placebo-Controlled Trial
Kranzler, H. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00135-9 · Cited by 209
Predicting Treatment Response to Naltrexone: The Influence of Craving and Family History
Monterosso, J. R., Flannery, B. A., Pettinati, H. M., Oslin, D. W., Rukstalis, M., O'Brien, C. P., & Volpicelli, J. R. (2001) · The American Journal on Addictions · doi:10.1080/105504901750532148 · Cited by 206
Analysis of Randomized Controlled Trials
Peduzzi, P. (2002) · Epidemiologic Reviews · doi:10.1093/epirev/24.1.26 · Cited by 201
Naltrexone for alcohol dependence: a randomized controlled trial
Morris, P. L. P., Hopwood, M., Whelan, G., Gardiner, J., & Drummond, E. (2001) · Addiction · doi:10.1046/j.1360-0443.2001.961115654.x · Cited by 200
Gelernter, J., Gueorguieva, R., Kranzler, H. R., Zhang, H., Cramer, J., Rosenheck, R., Krystal, J. H., & the VA Cooperative Study #425 Study Group (2007) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2007.00339.x · Cited by 200
Naltrexone blocks the post-shock increase of ethanol consumption
Volpicelli, J. R., Davis, M. A., & Olgin, J. E. (1986) · Life Sciences · doi:10.1016/0024-3205(86)90601-6 · Cited by 191
Naltrexone in the treatment of alcoholism: A clinical review
O'Brien, C. P., Volpicelli, L. A., & Volpicelli, J. R. (1996) · Alcohol · doi:10.1016/0741-8329(95)02038-1 · Cited by 189
Outcome selection bias in meta-analysis
Williamson, P. R., Gamble, C., Altman, D. G., & Hutton, J. L. (2005) · Statistical Methods in Medical Research · doi:10.1191/0962280205sm415oa · Cited by 188
Naltrexone and disulfiram in patients with alcohol dependence and comorbid psychiatric disorders
Petrakis, I. L., Poling, J., Levinson, C., Nich, C., Carroll, K., & Rounsaville, B. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.02.016 · Cited by 177
Lithium Treatment of Depressed and Nondepressed Alcoholics
Dorus, W. (1989) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1989.03430120100029 · Cited by 174
Sinclair, J. D. (2001) · Alcohol and Alcoholism · doi:10.1093/alcalc/36.1.2 · Cited by 174
Balldin, J., Berglund, M., Borg, S., Månsson, M., Bendtsen, P., Franck, J., Gustafsson, L., Halldin, J., Nilsson, L. ‐. H., Stolt, G., et al. (2003) · Alcoholism: Clinical and Experimental Research · doi:10.1097/01.alc.0000075548.83053.a9 · Cited by 173
Neuropharmacological treatments for alcoholism: scientific basis and clinical findings
Johnson, B. A., & Ait-Daoud, N. (2000) · Psychopharmacology · doi:10.1007/s002130000371 · Cited by 172
Kranzler, H. R., Wesson, D. R., Billot, L., & DrugAbuse Sciences Naltrexone Depot Study Group (2004) · Alcoholism: Clinical and Experimental Research · doi:10.1097/01.alc.0000130804.08397.29 · Cited by 169
Morley, K. C., Teesson, M., Reid, S. C., Sannibale, C., Thomson, C., Phung, N., Weltman, M., Bell, J. R., Richardson, K., & Haber, P. S. (2006) · Addiction · doi:10.1111/j.1360-0443.2006.01555.x · Cited by 165
Effects of Naltrexone on Alcohol Self-Administration in Heavy Drinkers
Davidson, D., Palfai, T., Bird, C., & Swift, R. (1999) · Alcoholism: Clinical & Experimental Research · doi:10.1097/00000374-199902000-00001 · Cited by 165
Compelling or irrelevant? Using number needed to treat can help decide
Citrome, L. (2008) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2008.01194.x · Cited by 158
Лааксонен, Э., Koski‐Jännes, A., Salaspuro, M. P., Ahtinen, H., & Alho, H. (2007) · Alcohol and Alcoholism · doi:10.1093/alcalc/agm136 · Cited by 150
Jaffe, A. J., Rounsaville, B. J., Chang, G., Schottenfeld, R. S., Meyer, R. E., & O'Malley, S. S. (1996) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.64.5.1044 · Cited by 149
Comparing topiramate with naltrexone in the treatment of alcohol dependence
Baltieri, D. A., Daró, F. R., Ribeiro, P. L., & De Andrade, A. G. (2008) · Addiction · doi:10.1111/j.1360-0443.2008.02355.x · Cited by 145
Naltrexone as an Adjunctive Treatment for Older Patients With Alcohol Dependence
Oslin, D. W., Liberto, J. G., O'Brien, J. T., Krois, S., & Norbeck, J. (1997) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-199700540-00007 · Cited by 143
On the Loss‐of‐Control Phenomenon in Alcoholism
Keller, M. (1972) · British Journal of Addiction to Alcohol & Other Drugs · doi:10.1111/j.1360-0443.1972.tb01188.x · Cited by 143
O’Malley, S. S., Rounsaville, B. J., Farren, C. K., Namkoong, K., Wu, R., Robinson, J., & O’Connor, P. G. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.14.1695 · Cited by 142
Drobes, D. J., Anton, R. F., Thomas, S. E., & Voronin, K. (2004) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000139704.88862.01 · Cited by 140
Tidey, J. W., Monti, P. M., Rohsenow, D. J., Gwaltney, C. J., Miranda, R., McGeary, J. E., MacKillop, J. M., Swift, R. M., Abrams, D. B., Shiffman, S. M., et al. (2007) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2007.00545.x · Cited by 139
Single‐ and Multiple‐Dose Pharmacokinetics of Long‐acting Injectable Naltrexone
Dunbar, J., Turncliff, R. Z., Dong, Q., Silverman, B. L., Ehrich, E. W., & Lasseter, K. C. (2006) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2006.00052.x · Cited by 131
Gastpar, M., Bonnet, U., Böning, J., Mann, K. F., Schmidt, L., Soyka, M., Wetterling, T., Kielstein, V., Labriola, D., & Croop, R. S. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200212000-00009 · Cited by 131
PROPHYLACTIC TREATMENT OF ALCOHOLISM BY LITHIUM CARBONATE A Controlled Study
Merry, J., Reynolds, C. W., Bailey, J., & Coppen, A. J. (1976) · The Lancet · doi:10.1016/s0140-6736(76)90784-4 · Cited by 129
Latt, N. C., Jurd, S. M., Houseman, J., & Wutzke, S. E. (2002) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2002.tb04550.x · Cited by 128
Karhuvaara, S., Simojoki, K., Virta, A., Rosberg, M., Löyttyniemi, E., Nurminen, T., Kallio, A., & Mäkelä, R. (2007) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2007.00401.x · Cited by 127
Experience of a "slip" among alcoholics treated with naltrexone or placebo
O’Malley, S. S., Jaffe, A. J., Rode, S., & Rounsaville, B. J. (1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.2.281 · Cited by 123
Naltrexone augmentation of neuroleptic treatment in alcohol abusing patients with schizophrenia
Petrakis, I. L., O’Malley, S. S., Rounsaville, B. J., Poling, J. C., McHugh-Strong, C., & Krystal, J. H. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1658-9 · Cited by 123
Pettinati, H. M., Volpicelli, J. R., Pierce, J. D., & O’Brien, C. P. (2000) · Journal of Addictive Diseases · doi:10.1300/j069v19n01_06 · Cited by 122
Hölter, S. M., & Spanagel, R. (1999) · Psychopharmacology · doi:10.1007/s002130051069 · Cited by 122
Anton, R. F., Moak, D. H., Latham, P., Waid, L. R., Myrick, H., Voronin, K., Thevos, A., Wang, W., & Woolson, R. (2005) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000172071.81258.04 · Cited by 121
Sustained‐Release Naltrexone for Alcoholism Treatment: A Preliminary Study
Kranzler, H. R., Modesto‐Lowe, V., & Nuwayser, E. S. (1998) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1998.tb03703.x · Cited by 118
Guardia, J., Caso, C., Árias, F., Gual, A., Sanahuja, J., Ramírez, M., Mengual, I., Gonzalvo, B., Segura, L., Trujols, J., et al. (2002) · PubMed · doi:10.1097/01.alc.0000030561.15921.a9 · Cited by 117
A Multi-site Dose Ranging Study of Nalmefene in the Treatment of Alcohol Dependence
Anton, R. F., Pettinati, H. M., Zweben, A., Kranzler, H. R., Johnson, B. A., Bohn, M. J., McCaul, M. E., Anthenelli, R. M., Salloum, I. M., Galloway, G. P., et al. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000130555.63254.73 · Cited by 117
NALTREXONE VERSUS ACAMPROSATE: ONE YEAR FOLLOW-UP OF ALCOHOL DEPENDENCE TREATMENT
Rubio, G. (2001) · Alcohol and Alcoholism · doi:10.1093/alcalc/36.5.419 · Cited by 116
Heyser, C. J., Moc, K., & Koob, G. F. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300175 · Cited by 113
The diagnosis of social phobia.
Greist, J. H. (1995) · PubMed · Cited by 113
Naltrexone Increases the Latency to Drink Alcohol in Social Drinkers
Davidson, D., Swift, R. M., & Fitz, E. (1996) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1996.tb01679.x · Cited by 111
A Pharmacokinetic and Pharmacodynamic Drug Interaction Study of Acamprosate and Naltrexone
Mason, B. J. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00368-8 · Cited by 110
A one-year pragmatic trial of naltrexone vs disulfiram in the treatment of alcohol dependence
DE SOUSA, A., & DE SOUSA, A. (2004) · Alcohol and Alcoholism · doi:10.1093/alcalc/agh104 · Cited by 108
Pettinati, H. M., Kampman, K. M., Lynch, K. G., Suh, J. J., Dackis, C. A., Oslin, D. W., & O’Brien, C. P. (2007) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2007.05.011 · Cited by 105
Martinotti, G., Nicola, M. D., Giannantonio, M. D., & Janiri, L. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108089596 · Cited by 104
O’Malley, S. S., Robin, R. W., Levenson, A. L., GreyWolf, I., Chance, L. E., Hodgkinson, C. A., Romano, D. M., Robinson, J., Meandzija, B., Stillner, V., et al. (2008) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2008.00682.x · Cited by 104
Brown, E. S., Carmody, T. J., Schmitz, J. M., Caetano, R., Adinoff, B. H., Swann, A. C., & Rush, A. J. (2009) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2009.01024.x · Cited by 101
Roozen, H. G., de Waart, R., van der Windt, D., van den Brink, W., de Jong, C. A. J., & Kerkhof, A. J. F. M. (2005) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.11.001 · Cited by 97
Pettinati, H. M., Kampman, K. M., Lynch, K. G., Xie, H., Dackis, C., Rabinowitz, A. R., & O′Brien, C. P. (2008) · Addictive Behaviors · doi:10.1016/j.addbeh.2007.11.011 · Cited by 95
Naltrexone treatment of comorbid alcohol and cocaine use disorders
Hersh, D., Kirk, J. R. V., & Kranzler, H. R. (1998) · Psychopharmacology · doi:10.1007/s002130050688 · Cited by 93
Rubio, G., Ponce, G., Rodríguez–Jiménez, R., Jiménez‐Arriero, M. Á., Hoenicka, J., & Palomo, T. (2005) · Alcohol and Alcoholism · doi:10.1093/alcalc/agh151 · Cited by 91
Anton, R. F., Moak, D. H., Latham, P. K., Waid, L. R., Malcolm, R. J., Dias, J. K., & Roberts, J. S. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200102000-00013 · Cited by 90
Tannock, I. F. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.3-4.206 · Cited by 90
Johnson, B. A., Ait‐Daoud, N., & Prihoda, T. J. (2000) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2000.tb02048.x · Cited by 89
Matsuzawa, S., Suzuki, T., Misawa, M., & Nagase, H. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00008-4 · Cited by 88
O'Malley, S. S., Sinha, R., Grilo, C. M., Capone, C., Farren, C. K., McKee, S. A., Rounsaville, B. J., & Wu, R. (2007) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2007.00347.x · Cited by 85
Carroll, K. M., Ziedonis, D. M., O’Malley, S. S., McCance‐Katz, E. F., Gordon, L. T., & Rounsaville, B. J. (1993) · American Journal on Addictions · doi:10.3109/10550499309115944 · Cited by 83
Prolonged Central μ-Opioid Receptor Occupancy after Single and Repeated Nalmefene Dosing
Ingman, K., Hagelberg, N. M., Aalto, S., Någren, K., Juhakoski, A., Karhuvaara, S., Kallio, A., Oikonen, V., Hietala, J. A., & Scheinin, H. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300790 · Cited by 83
Johnson, B. A., Ait‐Daoud, N., Aubin, H., van den Brink, W., Guzzetta, R. V., Loewy, J. W., Silverman, B. L., & Ehrich, E. W. (2004) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000139823.30096.52 · Cited by 82
Effect of acamprosate and naltrexone, alone or in combination, on ethanol consumption
Stromberg, M. F., Mackler, S. A., Volpicelli, J. R., & O’Brien, C. P. (2001) · Alcohol · doi:10.1016/s0741-8329(00)00137-3 · Cited by 81
Treatment of Late-Life Depression Complicated by Alcohol Dependence
Oslin, D. W. (2005) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200506000-00008 · Cited by 80
Naltrexone effects on ethanol consumption and response to ethanol conditioned cues in C57BL/6 mice
Middaugh, L. D., & Bandy, A. E. (2000) · Psychopharmacology · doi:10.1007/s002130000479 · Cited by 79
Nalmefene: Safety and Kinetics After Single and Multiple Oral Doses of a New Opioid Antagonist
Dixon, R., Gentile, J., Hsu, H., Hsiao, J. H., Howes, J. F., Garg, D. C., & Weidler, D. J. (1987) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1987.tb02191.x · Cited by 78
Role of Conditioning Factors in the Development of Drug Dependence
Childress, A. R., McLellan, A. T., & O’Brien, C. P. (1986) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(18)30603-8 · Cited by 78
Caputo, F., Addolorato, G., Lorenzini, F., Domenicali, M., Greco, G., Re, A. D., Gasbarrini, A., Stefanini, G. F., & Bernardi, M. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(02)00340-x · Cited by 77
Johnson, B. A., O’Malley, S. S., Ciraulo, D. A., Roache, J. D., Chambers, R. A., Sarid‐Segal, O., & Couper, D. J. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000084029.22282.bb · Cited by 76
Schmitz, J. M., Averill, P. M., Sayre, S. L., McCleary, P., Moeller, F. G., & Swann, A. C. (2002) · Addictive Disorders & Their Treatment · doi:10.1097/00132576-200205000-00004 · Cited by 75
Targeted Versus Daily Naltrexone: Secondary Analysis of Effects on Average Daily Drinking
Hernández–Ávila, C. A., Song, C., Kuo, L., Tennen, H. A., Armeli, S., & Kranzler, H. R. (2006) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2006.00101.x · Cited by 74
George, S. R., Roldan, L., Lui, A., & Naranjo, C. A. (1991) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1991.tb00576.x · Cited by 73
Advances in the Use of Naltrexone an Integration of Preclinical and Clinical Findings
O’Malley, S. S., & Froehlich, J. C. (2002) · Springer eBooks · doi:10.1007/0-306-47939-7_17 · Cited by 70
The Effects of Naltrexone on Alcohol and Cocaine Use in Dually Addicted Patients
Oslin, D. W., Pettinati, H. M., Volpicelli, J. R., Wolf, A. L., Kampman, K. M., & O’Brien, C. P. (1999) · Journal of Substance Abuse Treatment · doi:10.1016/s0740-5472(98)00039-7 · Cited by 69
Predictors of Compliance with Naltrexone Among Alcoholics
Rohsenow, D. J., Colby, S. M., Monti, P. M., Swift, R. M., Martin, R. A., Mueller, T. I., Gordon, A. A., & Eaton, C. A. (2000) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2000.tb04573.x · Cited by 68
General Versus Systematic Inquiry about Emergent Clinical Events with SAFTEE
Rabkin, J. G., Markowitz, J. S., OCEPEK-WELIKSON, K., & Wager, S. (1992) · Current Opinion in Cardiology · doi:10.1097/00001573-199202000-00002 · Cited by 67
Prolonged blockade of opioid effect with oral nalmefene
Gal, T. J., DiFazio, C. A., & Dixon, R. (1986) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1986.220 · Cited by 67
Targeted naltrexone treatment of early problem drinkers
Kranzler, H. R., Tennen, H. A., Penta, C., & Bohn, M. J. (1997) · Addictive Behaviors · doi:10.1016/s0306-4603(96)00064-0 · Cited by 67
Oslin, D. W., Lynch, K. G., Pettinati, H. M., Kampman, K. M., Gariti, P., Gelfand, L. A., Have, T. T., Wortman, S. P., Dundon, W. D., Dackis, C. A., et al. (2008) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2008.00698.x · Cited by 66
Naltrexone Treatment of Adolescent Alcoholics: An Open-Label Pilot Study
Deas, D., Kim May, M. P. H., Randall, C. L., Johnson, N., & Anton, R. F. (2005) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2005.15.723 · Cited by 65
Martinotti, G., Nicola, M. D., Romanelli, R., Andreoli, S., Pozzi, G., Moroni, N., & Janiri, L. (2007) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.833 · Cited by 65
Ooteman, W., Koeter, M. W. J., Verheul, R., Schippers, G. M., & van den Brink, W. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2007.02.012 · Cited by 65
Direct and Indirect Costs Attributable to Alcohol Consumption in Germany
Konnopka, A., & nig, H.-H. K. (2007) · PharmacoEconomics · doi:10.2165/00019053-200725070-00006 · Cited by 63
Caputo, F., Addolorato, G., Stoppo, M., Francini, S., Vignoli, T., Lorenzini, F., Re, A. D., Comaschi, C., Andreoné, P., Trevisani, F., et al. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2007.04.008 · Cited by 62
Alcohol drinking in rats during and following morphine injections
Volpicelli, J. R., Ulm, R. R., & Hopson, N. (1991) · Alcohol · doi:10.1016/0741-8329(91)90401-h · Cited by 60
Treatment of Cocaine‐Alcohol Dependence with Naltrexone and Relapse Prevention Therapy
Schmitz, J. M., Stotts, A. L., Sayre, S. L., DeLaune, K. A., & Grabowski, J. G. (2004) · American Journal on Addictions · doi:10.1080/10550490490480982 · Cited by 60
Effectiveness of Naltrexone in a Community Treatment Program
Killeen, T. K., Brady, K. T., Gold, P. B., Simpson, K. N., Faldowski, R. A., Tyson, C., & Anton, R. F. (2004) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000145688.30448.2c · Cited by 60
Differential naltrexone antagonism of hydromorphone and pentazocine effects in human volunteers.
Preston, K. L., & Bigelow, G. E. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10212-7 · Cited by 60
Serum 6-Beta-Naltrexol Levels Are Related to Alcohol Responses in Heavy Drinkers
McCaul, M. E., Wand, G. S., Rohde, C. A., & Lee, S. M. (2000) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2000.tb02107.x · Cited by 59
Persistence with oral naltrexone for alcohol treatment: implications for health‐care utilization
Kranzler, H. R., Stephenson, J. J., Montejano, L. B., Wang, S. S., & Gastfriend, D. R. (2008) · Addiction · doi:10.1111/j.1360-0443.2008.02345.x · Cited by 58
O’Malley, S. S., Krishnan‐Sarin, S., Farren, C. K., & O’Connor, P. G. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200002000-00012 · Cited by 58
Sweet Liking Phenotype, Alcohol Craving and Response to Naltrexone Treatment in Alcohol Dependence
Garbutt, J. C., Osborne, M., Gallop, R., Barkenbus, J., Grace, K., Cody, M. W., Flannery, B., & Kampov‐Polevoy, A. B. (2009) · Alcohol and Alcoholism · doi:10.1093/alcalc/agn122 · Cited by 52
Sobell, L. C., Toneatto, T., Sobell, M. B., Leo, G. I., & Johnson, L. M. (1992) · Addictive Behaviors · doi:10.1016/0306-4603(92)90011-j · Cited by 51
High-Dose Naltrexone Therapy for Cocaine-Alcohol Dependence
Schmitz, J. M., Lindsay, J. A., Green, C. E., Herin, D. V., Stotts, A. L., & Moeller, F. G. (2009) · American Journal on Addictions · doi:10.3109/10550490903077929 · Cited by 51
Kranzler, H. R., Armeli, S., Feinn, R., & Tennen, H. A. (2004) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.72.2.317 · Cited by 48
Galloway, G. P., Koch, M., Cello, R., & Smith, D. E. (2005) · BMC Psychiatry · doi:10.1186/1471-244x-5-18 · Cited by 47
Effects of naltrexone on cue-elicited craving for alcohol and cocaine
Modesto‐Lowe, V., Burleson, J. A., Hersh, D., Bauer, L. O., & Kranzler, H. R. (1997) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(97)00134-8 · Cited by 47
Naltrexone and Brief Counseling to Reduce Heavy Drinking: Results of a Small Clinical Trial
Bohn, M. J., Kranzler, H. R., Beazoglou, D., & Staehler, B. A. (1994) · American Journal on Addictions · doi:10.1111/j.1521-0391.1994.tb00375.x · Cited by 44
Evaluation of lithium therapy for alcoholism.
FAWCETT, J. A., Clark, D. C., Gibbons, R. D., Aagesen, C. A., Pisani, V. D., Tilkin, J. M., Sellers, D. R., & Stutzman, D. L. (1984) · PubMed · Cited by 42
Huang, M., Chen, C.-Y. O., Yu, J., & Chen, C. (2005) · Addiction Biology · doi:10.1080/13556210500223504 · Cited by 41
Comparing Treatments of Alcoholism on Craving and Biochemical Measures of Alcohol Consumptions
Nava, F. A., Premi, S., Manzato, E., & Lucchini, A. (2006) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2006.10399846 · Cited by 39
Stella, L., Addolorato, G., Rinaldi, B., Capuano, A., Berrino, L., Rossi, F., & Maione, S. (2008) · Pharmacological Research · doi:10.1016/j.phrs.2008.03.001 · Cited by 34
Modulation of ethanol-intake by morphine: Evidence for a central site of action
Wild, K. D., & Reid, L. D. (1990) · Life Sciences · doi:10.1016/0024-3205(90)90221-c · Cited by 34
Naltrexone improves outcome of a controlled drinking program
Rubio, G., Manzanares, J., Lopez-Munoz, F. J., Álamo, C., Ponce, G., Jiménez‐Arriero, M. Á., & Palomo, T. (2002) · Journal of Substance Abuse Treatment · doi:10.1016/s0740-5472(02)00296-9 · Cited by 33
A double-blind, placebo-controlled study of sertraline with naltrexone for alcohol dependence
Farren, C. K., Scimeca, M. M., Wu, R., & Malley, S. (2008) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.06.006 · Cited by 31
Drinking in alcoholics following an alcohol challenge research protocol.
Drobes, D. J., & Anton, R. F. (2000) · Journal of Studies on Alcohol · doi:10.15288/jsa.2000.61.220 · Cited by 31
Naltrexone in the treatment of male alcoholics - an effectiveness study in Singapore
Lee, A. M., Tan, S., Lim, D., Winslow, R. M., Wong, K. E., Allen, J., Hall, W., & Parker, G. B. (2001) · Drug and Alcohol Review · doi:10.1080/09595230124192 · Cited by 28
Naltrexone and brief counseling to reduce heavy drinking in hazardous drinkers
Davidson, D., Saha, C., Scifres, S. L., Daggy, J., O’Connor, S., & Selzer, C. (2004) · Addictive Behaviors · doi:10.1016/j.addbeh.2004.03.027 · Cited by 27
Park, T., & Lee, S.-Y. (1999) · Statistics in Medicine · Cited by 25
DeHaven‐Hudkins, D. L., Brostrom, P. A., Allen, J. T., Lesko, L. J., Ferkany, J. W., Kaplita, P. V., Mavunkel, B. J., Rzeszotarski, W. J., & Steranka, L. R. (1990) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(90)90019-e · Cited by 24
Hermos, J. A., Young, M., GAGNON, D. R., & Fiore, L. D. (2004) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000134234.39303.17 · Cited by 24
Tolerability of Naltrexone in Treating Older, Alcohol-Dependent Patients
Oslin, D. W., Liberto, J. G., O’Brien, J. F., & Krois, S. (1997) · American Journal on Addictions · doi:10.1111/j.1521-0391.1997.tb00406.x · Cited by 22
Davidson, D., Gulliver, S. B., Longabaugh, R., Wirtz, P. W., & Swift, R. M. (2007) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.2007.68.238 · Cited by 21
Using Naltrexone in Inpatient Alcoholism Treatment
Knox, P. C., & Donovan, D. M. (1999) · Journal of Psychoactive Drugs · doi:10.1080/02791072.1999.10471767 · Cited by 20
Krishnan‐Sarin, S., O’Malley, S. S., & Krystal, J. H. (2008) · Europe PMC (PubMed Central) · Cited by 19
Feeney, G. F. X., Feeney, G. F. X., Young, R. M., Connor, J. P., Tucker, J., & McPherson, A. (2001) · Australian & New Zealand Journal of Psychiatry · doi:10.1046/j.1440-1614.2001.00935.x · Cited by 19
Treatment of Alcohol and Drug Abuse. An Evidence-Based Review
Berglund, M. (2003) · Lund University Publications (Lund University) · Cited by 18
NALTREXONE EXERTS A FAVOURABLE EFFECT ON PLASMA LIPIDS IN ABSTINENT PATIENTS WITH ALCOHOL DEPENDENCE
Budzyński, J., Rybakowski, J., Swiatkowski, M., Torliński, L., Kłopocka, M., Kosmowski, W., & Ziółkowski, M. (2000) · Alcohol and Alcoholism · doi:10.1093/alcalc/35.1.91 · Cited by 18
A randomized control trial of group counseling in a naltrexone treatment program
Tucker, T., Ritter, A. J., Maher, C., & Jackson, H. J. (2004) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2004.08.003 · Cited by 17
Long-term effects of pharmacotherapy on relapse prevention in alcohol dependence
Kiefer, F., Andersohn, F., Otte, C., Wolf, K., Jahn, H., & Wiedemann, K. (2004) · Acta Neuropsychiatrica · doi:10.1111/j.0924-2708.2004.00093.x · Cited by 17
Buri, C., Moggi, F., Giovanoli, A., & Strik, W. K. (2007) · Alcohol and Alcoholism · doi:10.1093/alcalc/agm038 · Cited by 17
Naltrexone’s suppressant effects on drinking are limited to the first 3 months of treatment
Davidson, D., Wirtz, P. W., Gulliver, S. B., & Longabaugh, R. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0807-y · Cited by 14
A brief 7-day estimate of alcohol consumption for use in smoking cessation clinical trials
Toll, B. A., Leeman, R. F., McKee, S. A., & O’Malley, S. S. (2008) · Addictive Behaviors · doi:10.1016/j.addbeh.2008.07.007 · Cited by 13
[Efficacy of naltrexone in the treatment of alcohol dependence disorder in women].
Ponce, G., Sánchez-García, J., Rubio, G., Rodríguez–Jiménez, R., Jiménez‐Arriero, M. Á., & Palomo, T. (2005) · PubMed · Cited by 11
Meta-Analysis of Pharmacotherapeutic Trials
Schoechlin, C., & Engel, R. R. (2000) · Handbooks of pharmacology and toxicology · doi:10.1201/9781420036961.ch31 · Cited by 9
Cited by
Garvey, W. T., Mechanick, J. I., Brett, E. M., Garber, A. J., Hurley, D. L., Jastreboff, A. M., Nadolsky, K., Pessah-Pollack, R., & Plodkowski, R. (2016) · Endocrine Practice · doi:10.4158/ep161365.gl · Cited by 1,914
Industry sponsorship and research outcome
Lundh, A., Lexchin, J., Mintzes, B., Schroll, J. B., & Bero, L. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.mr000033.pub3 · Cited by 1,697
Effectiveness and cost-effectiveness of policies and programmes to reduce the harm caused by alcohol
Anderson, P., Chisholm, D., & Fuhr, D. C. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60744-3 · Cited by 1,102
Treatment and prevention of mental disorders in low-income and middle-income countries
Patel, V., Araya, R., Chatterjee, S., Chisholm, D., Cohen, A., De Silva, M., Hosman, C., McGuire, H., Rojas, G., & van Ommeren, M. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61240-9 · Cited by 930
Garbutt, J. C., Kranzler, H. R., O’Malley, S. S., Gastfriend, D. R., Pettinati, H. M., Silverman, B. L., Loewy, J. W., Ehrich, E. W., & Vivitrex Study Group, F. T. (2005) · JAMA · doi:10.1001/jama.293.13.1617 · Cited by 635
Metadata
- Authors
- Srisurapanont, M., & Jarusuraisin, N.
- Venue
- The Cochrane Database of Systematic Reviews
- Publisher
- John Wiley & Sons, Ltd
- Published
- 2002-04-22
- Issue
- 12
- Pages
- CD001867-CD001867
- OpenAlex
- W1635084872
- Cited by
- 764
- References
- 197
- Type
- reference entry
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.